BRIGHT MINDS BIOSCIENCES INC. (DRUG) — Institutional Holders, Q2 2026

100 institutional investment managers reported a DRUG position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $653.8M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

DRUG in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

19

Added to

47

Trimmed

17

Sold out

11

Biggest buyers

  1. Point72 Asset Management, L.P.New · +327,416 sh+$23.0M
  2. Parkman Healthcare PartnersAdded · +164,955 sh+$11.6M
  3. CITADEL ADVISORSNew · +66,533 sh+$4.7M
  4. BlackRockAdded · +64,251 sh+$4.5M
  5. Trexquant InvestmentAdded · +63,164 sh+$4.4M

Biggest sellers

  1. PERCEPTIVE ADVISORSSold out · -377,544 sh-$26.5M
  2. ADAGE CAPITAL PARTNERS GP, L.L.C.Trimmed · -160,743 sh-$11.3M
  3. Cormorant Asset ManagementTrimmed · -159,331 sh-$11.2M
  4. MORGAN STANLEYTrimmed · -114,165 sh-$8.0M
  5. GREAT POINT PARTNERSTrimmed · -110,397 sh-$7.7M

DRUG 13F holders ranked 1–100 of 100

Institutional investors reporting a position in BRIGHT MINDS BIOSCIENCES INC. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Jupiter Topco#1 · 1,349,107 sh$94.8M—
Cormorant Asset Management#2 · 900,000 sh$63.2M-15.0%
BlackRock#3 · 686,184 sh$48.2M+10.3%
Vivo Capital#4 · 557,172 sh$39.1M0.0%
Vestal Point Capital#5 · 545,000 sh$38.3M+10.7%
BRAIDWELL#6 · 483,822 sh$34.0M-10.4%
DRIEHAUS CAPITAL MANAGEMENT#7 · 433,377 sh$30.4M+0.2%
BALYASNY ASSET MANAGEMENT L.P.#8 · 345,053 sh$24.2M+16.1%
ADAGE CAPITAL PARTNERS GP, L.L.C.#9 · 335,000 sh$23.5M-32.4%
Point72 Asset Management, L.P.#10 · 327,416 sh$23.0MNew
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)#11 · 283,000 sh$19.9M0.0%
RA CAPITAL MANAGEMENT, L.P.#12 · 265,000 sh$18.6M0.0%
Parkman Healthcare Partners#13 · 205,053 sh$14.4M+411.4%
MPM BioImpact#14 · 202,114 sh$14.2M-4.7%
WELLINGTON MANAGEMENT GROUP LLP#15 · 171,315 sh$12.0M+25.3%
GOLDMAN SACHS GROUP#16 · 133,689 sh$9.4M+79.8%
EVENTIDE ASSET MANAGEMENT#17 · 130,013 sh$9.1M0.0%
STATE STREET#18 · 122,178 sh$8.6M+12.9%
SEVEN GRAND MANAGERS#19 · 120,000 sh$8.4M0.0%
GREAT POINT PARTNERS#20 · 109,603 sh$7.7M-50.2%
GEODE CAPITAL MANAGEMENT#21 · 104,146 sh$7.3M+17.4%
ORBIMED ADVISORS#22 · 93,000 sh$6.5M+132.5%
ACUTA CAPITAL PARTNERS#23 · 92,745 sh$6.5M-17.2%
Ikarian Capital#24 · 88,951 sh$6.2M-46.6%
VANGUARD PORTFOLIO MANAGEMENT#25 · 80,060 sh$5.6M+32.4%
Sio Capital Management#26 · 73,952 sh$5.2M-14.1%
Trexquant Investment#27 · 70,615 sh$5.0M+847.7%
B Group#28 · 67,500 sh$4.7M0.0%
MILLENNIUM MANAGEMENT#29 · 66,740 sh$4.7M+26.3%
CITADEL ADVISORS#30 · 66,533 sh$4.7MNew
Schonfeld Strategic Advisors#31 · 66,277 sh$4.7M+400.4%
Walleye Capital#32 · 66,106 sh$4.6M+23.1%
Woodline Partners#33 · 45,668 sh$3.2M0.0%
NORTHERN#34 · 42,466 sh$3.0M+13.6%
Artia Global Partners#35 · 38,407 sh$2.7M0.0%
AMERIPRISE FINANCIAL#36 · 37,902 sh$2.7M-24.2%
LOS ANGELES CAPITAL MANAGEMENT#37 · 35,747 sh$2.5MNew
KVP Capital Advisors#38 · 31,813 sh$2.2M0.0%
SUPERSTRING CAPITAL MANAGEMENT#39 · 30,456 sh$2.1M+128.8%
ADAR1 Capital Management#40 · 30,300 sh$2.1M-10.6%
BOOTHBAY FUND MANAGEMENT#41 · 27,870 sh$2.0M-45.7%
BANK OF AMERICA#42 · 26,966 sh$1.9M+38.8%
AdvisorShares Investments#43 · 24,274 sh$1.7M+92.5%
Aquatic Capital Management#44 · 20,831 sh$1.5M+918.6%
PLATINUM INVESTMENT MANAGEMENT LTD#45 · 19,127 sh$1.3M0.0%
MORGAN STANLEY#46 · 18,599 sh$1.3M-86.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT#47 · 18,032 sh$1.3M+17.7%
Nuveen#48 · 16,889 sh$1.2M+102.8%
UBS Group AG#49 · 15,536 sh$1.1M+17.0%
Bank of New York Mellon#50 · 14,902 sh$1.0M+12.4%
Exome Asset Management#51 · 10,110 sh$709.7KNew
TWO SIGMA INVESTMENTS#52 · 9,606 sh$674.3KNew
RHUMBLINE ADVISERS#53 · 8,733 sh$613.1K+12.5%
TUDOR INVESTMENT ET AL#54 · 8,291 sh$582.0KNew
FRANKLIN RESOURCES#55 · 8,020 sh$563.0KNew
FMR#56 · 7,851 sh$551.2K+858.6%
DEUTSCHE BANK AG\#57 · 7,808 sh$548.1K+24.8%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP#58 · 7,199 sh$505.4KNew
VANGUARD FIDUCIARY#59 · 7,001 sh$491.5K+15.5%
LPL Financial#60 · 6,895 sh$484.0K+6.2%
WELLS FARGO & COMPANY#61 · 6,761 sh$474.6K+167.0%
JANE STREET GROUP#62 · 6,400 sh$449.3K0.0%
Seven Fleet Capital Management#63 · 6,395 sh$448.9K0.0%
PRICE T ROWE ASSOCIATES#64 · 6,167 sh$433.0K+24.7%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM#65 · 6,091 sh$427.6K+61.1%
ALLIANCEBERNSTEIN L.P.#66 · 5,680 sh$414.5KNew
Engineers Gate Manager#67 · 5,412 sh$379.9KNew
DnB Asset Management AS#68 · 4,822 sh$338.5K+8.6%
JPMORGAN CHASE#69 · 4,778 sh$330.5K+23.2%
MetLife Investment Management#70 · 4,511 sh$316.7K+15.3%
Invesco Ltd.#71 · 4,016 sh$281.9K-36.2%
Vanguard Global Advisers#72 · 3,870 sh$271.7K+26.6%
CITIGROUP#73 · 3,612 sh$259.7K+1116.2%
MIRAE ASSET GLOBAL ETFS Ltd.#74 · 3,412 sh$239.5K+4.7%
STRS OHIO#75 · 3,300 sh$231.7K+22.2%
BARCLAYS PLC#76 · 3,256 sh$228.6K+5.8%
NEW YORK STATE COMMON RETIREMENT FUND#77 · 2,600 sh$182.5K0.0%
Russell Investments Group, Ltd.#78 · 2,553 sh$179.2K+189.5%
Police & Firemen's Retirement System of New Jersey#79 · 2,036 sh$142.9K0.0%
BNP PARIBAS FINANCIAL MARKETS#80 · 1,234 sh$86.6K-21.5%
Caitong International Asset Management , Ltd#81 · 1,201 sh$84.3KNew
ROYAL BANK OF CANADA#82 · 1,133 sh$80.0K+179.1%
Tower Research Capital (TRC)#83 · 1,011 sh$71.0K+69.3%
Legal & General Group Plc#84 · 718 sh$50.5K+16.6%
Ameritas Investment Partners#85 · 672 sh$47.2K+43.0%
China Universal Asset Management , Ltd.#86 · 600 sh$42.1K+20.0%
State of Wyoming#87 · 479 sh$33.6KNew
Pinnacle Wealth Planning Services#88 · 138 sh$9.7KNew
OSAIC#89 · 80 sh$5.6KNew
Allworth Financial#90 · 48 sh$3.4K+1500.0%
Quarry#91 · 27 sh$1.9KNew
Sterling Capital Management#92 · 26 sh$1.8K-42.2%
GAMMA Investing#93 · 20 sh$1.4K-39.4%
Integrated Wealth Concepts#94 · 20 sh$1.4KNew
TD Waterhouse Canada#95 · 20 sh$1.3KNew
SRS Capital Advisors#96 · 11 sh$772.00New
Bell Investment Advisors#97 · 6 sh$422.000.0%
SBI Securities , Ltd.#98 · 5 sh$351.000.0%
SJS Investment Consulting#99 · 5 sh$351.00New
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#100 · 98 sh—-74.2%

Funds that sold out of DRUG in Q2 2026 (11)

Held DRUG at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held DRUG in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
PERCEPTIVE ADVISORS377,544 sh$27.5M
D. E. Shaw15,445 sh$1.1M
SEI INVESTMENTS11,188 sh$816.4K
Ghisallo Capital Management11,000 sh$802.7K
Informed Momentum9,189 sh$670.5K
Quadrature Capital Ltd6,498 sh$474.2K
SUSQUEHANNA INTERNATIONAL GROUP, LLP3,141 sh$229.2K
Virtu Financial3,129 sh$228.0K
Persistent Asset Partners Ltd2,310 sh$168.6K
MAI Capital Management1 sh$73.00
TWIN PEAKS WEALTH ADVISORS1 sh$73.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.